ID   SKBR3-PR
AC   CVCL_EQ69
SY   SKBR3 PR
DR   GEO; GSM183442
DR   GEO; GSM183443
DR   Wikidata; Q54954676
RX   PubMed=17560336;
CC   Knockout cell: Method=shRNA knockdown; HGNC; 9588; PTEN.
CC   Sequence variation: Homozygous for CDH1 deletion (from parent cell line).
CC   Sequence variation: Homozygous for TP53 p.Arg175His (c.524G>A) (ClinVar=VCV000012374) (from parent cell line).
CC   Omics: Transcriptome analysis.
CC   Derived from metastatic site: Pleural effusion.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 02-07-20; Version: 5
//
RX   PubMed=17560336; DOI=10.1016/j.ccr.2007.04.021;
RA   Vivanco I., Palaskas N., Tran C., Finn S.P., Getz G., Kennedy N.J.,
RA   Jiao J., Rose J., Xie W., Loda M., Golub T.R., Mellinghoff I.K.,
RA   Davis R.J., Wu H., Sawyers C.L.;
RT   "Identification of the JNK signaling pathway as a functional target of
RT   the tumor suppressor PTEN.";
RL   Cancer Cell 11:555-569(2007).
//